Literature DB >> 21257733

Lewy bodies and olfactory dysfunction in old age.

Robert S Wilson1, Lei Yu, Julie A Schneider, Steven E Arnold, Aron S Buchman, David A Bennett.   

Abstract

As part of a clinical-pathologic project, older people completed a standard odor identification test at study entry. During a mean of 3.5 years of observation, 201 people died and underwent brain autopsy and neuropathologic examination (6 with a history of Parkinson's disease were excluded). Lewy bodies were identified with antibodies to alpha-synuclein and classified as nigral, limbic, or neocortical based on their distribution in 6 brain regions. Plaques and tangles in 5 regions were summarized with a previously established composite measure, and neuron loss in the substantia nigra was rated on 6-point scale. Odor identification scores ranged from 0 to 12 correct (mean = 8.0, standard deviation = 2.6). On neuropathologic examination, 26 persons had Lewy bodies (13 neocortical, 9 limbic, and 4 nigral). In an analysis adjusted for age, sex, education, and time from olfactory testing to death, limbic (estimate = -2.47, standard error [SE] = 0.73, P < 0.001) and neocortical (estimate = -4.36, SE = 0.63, P < 0.001) Lewy body subgroups were associated with impaired olfaction. Results were comparable in analyses that controlled for dementia or parkinsonism during the study or postmortem measures of plaques and tangles or nigral cell loss. A final set of analyses suggested that impaired olfactory performance may aid detection of underlying Lewy body disease. The findings indicate that Lewy body disease impairs late life olfactory function even in otherwise asymptomatic individuals.

Entities:  

Mesh:

Year:  2011        PMID: 21257733      PMCID: PMC3073534          DOI: 10.1093/chemse/bjq139

Source DB:  PubMed          Journal:  Chem Senses        ISSN: 0379-864X            Impact factor:   3.160


  44 in total

1.  Odor identification: influences of age, gender, cognition, and personality.

Authors:  M Larsson; D Finkel; N L Pedersen
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2000-09       Impact factor: 4.077

2.  Neurodegenerative basis of age-related cognitive decline.

Authors:  R S Wilson; S E Leurgans; P A Boyle; J A Schneider; D A Bennett
Journal:  Neurology       Date:  2010-09-15       Impact factor: 9.910

3.  Association of olfactory dysfunction with risk for future Parkinson's disease.

Authors:  G Webster Ross; Helen Petrovitch; Robert D Abbott; Caroline M Tanner; Jordan Popper; Kamal Masaki; Lenore Launer; Lon R White
Journal:  Ann Neurol       Date:  2008-02       Impact factor: 10.422

4.  Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis.

Authors:  G Tissingh; H W Berendse; P Bergmans; R DeWaard; B Drukarch; J C Stoof; E C Wolters
Journal:  Mov Disord       Date:  2001-01       Impact factor: 10.338

5.  Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment.

Authors:  Robert S Wilson; Sue E Leurgans; Patricia A Boyle; David A Bennett
Journal:  Arch Neurol       Date:  2011-03

6.  Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.

Authors:  R H McShane; Z Nagy; M M Esiri; E King; C Joachim; N Sullivan; A D Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

7.  Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.

Authors:  S S Williams; J Williams; M Combrinck; S Christie; A D Smith; R McShane
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06       Impact factor: 10.154

8.  Incidental Lewy body disease and preclinical Parkinson disease.

Authors:  Anthony DelleDonne; Kevin J Klos; Hiroshige Fujishiro; Zeshan Ahmed; Joseph E Parisi; Keith A Josephs; Roberta Frigerio; Melinda Burnett; Zbigniew K Wszolek; Ryan J Uitti; J Eric Ahlskog; Dennis W Dickson
Journal:  Arch Neurol       Date:  2008-08

9.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Authors:  Thomas G Beach; Charles H Adler; LihFen Lue; Lucia I Sue; Jyothi Bachalakuri; Jonette Henry-Watson; Jeanne Sasse; Sarah Boyer; Scophil Shirohi; Reed Brooks; Jennifer Eschbacher; Charles L White; Haru Akiyama; John Caviness; Holly A Shill; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2009-04-28       Impact factor: 17.088

10.  Olfactory impairment in presymptomatic Alzheimer's disease.

Authors:  Robert S Wilson; Steven E Arnold; Julie A Schneider; Patricia A Boyle; Aron S Buchman; David A Bennett
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

View more
  36 in total

1.  Conscientiousness, dementia related pathology, and trajectories of cognitive aging.

Authors:  Robert S Wilson; Patricia A Boyle; Lei Yu; Eisuke Segawa; Joel Sytsma; David A Bennett
Journal:  Psychol Aging       Date:  2015-02-09

2.  Terminal decline in motor function.

Authors:  Robert S Wilson; Eisuke Segawa; Aron S Buchman; Patricia A Boyle; Loren P Hizel; David A Bennett
Journal:  Psychol Aging       Date:  2012-05-21

3.  Overview and findings from the rush Memory and Aging Project.

Authors:  David A Bennett; Julie A Schneider; Aron S Buchman; Lisa L Barnes; Patricia A Boyle; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 4.  At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Authors:  Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

5.  Neocortical Lewy bodies are associated with impaired odor identification in community-dwelling elders without clinical PD.

Authors:  Sukriti Nag; Lei Yu; Veronique G VanderHorst; Julie A Schneider; David A Bennett; Aron S Buchman; Robert S Wilson
Journal:  J Neurol       Date:  2019-09-18       Impact factor: 4.849

Review 6.  Assessment of direct knowledge of the human olfactory system.

Authors:  Gregory Lane; Guangyu Zhou; Torben Noto; Christina Zelano
Journal:  Exp Neurol       Date:  2020-04-09       Impact factor: 5.330

Review 7.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

Review 8.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 9.  Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.

Authors:  Katie Hoyles; Jagdish C Sharma
Journal:  J Neurol       Date:  2013-02-03       Impact factor: 4.849

10.  Clinical-pathologic study of depressive symptoms and cognitive decline in old age.

Authors:  Robert S Wilson; Ana W Capuano; Patricia A Boyle; George M Hoganson; Loren P Hizel; Raj C Shah; Sukriti Nag; Julie A Schneider; Steven E Arnold; David A Bennett
Journal:  Neurology       Date:  2014-07-30       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.